NIAID Banner Logo Image

HIV Citation List: May 11 - May 24, 2012

Pubmed citations

1. Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse Transcriptase Inhibitors. Brehm, J.H., D.L. Koontz, C.L. Wallis, K.A. Shutt, I. Sanne, R. Wood, J.A. McIntyre, W.S. Stevens, N. Sluis-Cremer, and J.W. Mellors, Clinical Infectious Disease, 2012. [Epub ahead of print]; PMID[22618567].

[PubMed]. HIV_0511-052412.

2. Identification of HIV-1 Inhibitors Targeting the Nucleocapsid Protein. Breuer, S., M.W. Chang, J. Yuan, and B.E. Torbett, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22587465].

[PubMed]. HIV_0511-052412.

3. Reformulated Tenofovir Gel for Use as a Dual Compartment Microbicide. Dezzutti, C.S., L.C. Rohan, L. Wang, K. Uranker, C. Shetler, M. Cost, J.D. Lynam, and D. Friend, Journal of Antimicrobial Chemotherapy, 2012. [Epub ahead of print]; PMID[22581908].

[PubMed]. HIV_0511-052412.

4. Combinations of Griffithsin with Other Carbohydrate-binding Agents (CBAs) Demonstrate Superior Activity against HIV-1, HIV-2 and Selected CBA-resistant HIV-1 Strains. Ferir, G., D. Huskens, K.E. Palmer, D.M. Boudreaux, M.M. Swanson, D.M. Markovitz, J. Balzarini, and D. Schols, AIDS Research and Human Retroviruses, 2012. [Epub ahead of print]; PMID[22607556].

[PubMed]. HIV_0511-052412.

5. Correction to Design, Synthesis, and X-ray Crystallographic Analysis of a Novel Class of HIV-1 Protease Inhibitors. Ganguly, A.K., S.S. Alluri, D. Caroccia, D. Biswas, C.H. Wang, E. Kang, Y. Zhang, A.T. McPhail, S.S. Carroll, C. Burlein, V. Munshi, P. Orth, and C. Strickland, Journal of Medicinal Chemistry, 2012. [Epub ahead of print]; PMID[22607096].

[PubMed]. HIV_0511-052412.

6. Retrocyclin RC-101 Blocks HIV-1 Transmission across Cervical Mucosa in an Organ Culture. Gupta, P., D. Ratner, M. Ding, B. Patterson, L.C. Rohan, T.A. Reinhart, V. Ayyavoo, X. Huang, D.L. Patton, B. Ramratnam, and A.M. Cole, Journal of Acquired Immune Deficiency Syndrome, 2012. [Epub ahead of print]; PMID[22592582].

[PubMed]. HIV_0511-052412.

7. A High-throughput Assay for HIV-1 Integrase 3'-processing Activity Using Time-resolved Fluorescence. Han, Y.S., P. Quashie, T. Mesplede, H. Xu, K. Mekhssian, C. Fenwick, and M.A. Wainberg, Journal of Virological Methods, 2012. [Epub ahead of print]; PMID[22584270].

[PubMed]. HIV_0511-052412.

8. A Comparative Study of Backbone Versus Side Chain Peptide Cyclization: Application for HIV-1 Integrase Inhibitors. Hayouka, Z., A. Levin, M. Hurevich, D.E. Shalev, A. Loyter, C. Gilon, and A. Friedler, Bioorganic & Medicinal Chemistry, 2012. 20(10): p. 3317-3322; PMID[22507205].

[PubMed]. HIV_0511-052412.

9. CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant. Kang, Y., Z. Wu, T.C. Lau, X. Lu, L. Liu, A.K. Cheung, Z. Tan, J. Ng, J. Liang, H. Wang, S. Li, B. Zheng, B. Li, L. Chen, and Z. Chen, Journal of Biological Chemistry, 2012. 287(20): p. 16499-16509; PMID[22447925].

[PubMed]. HIV_0511-052412.

10. Energetics of Mutation-induced Changes in Potency of Lersivirine against HIV-1 Reverse Transcriptase. Kar, P. and V. Knecht, Journal of Physical Chemistry B, 2012. [Epub ahead of print]; PMID[22574920].

[PubMed]. HIV_0511-052412.

11. Maraviroc and Other HIV-1 Entry Inhibitors Exhibit a Class-specific Redistribution Effect That Results in Increased Extracellular Viral Load. Kramer, V.G., S.M. Schader, M. Oliveira, S. Colby-Germinario, D.A. Donahue, D.N. Singhroy, R. Tressler, R.D. Sloan, and M.A. Wainberg, Antimicrobial Agents and Chemotherapy, 2012. [Epub ahead of print]; PMID[22615275].

[PubMed]. HIV_0511-052412.

12. Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1. Li, L., Y. Ben, S. Yuan, S. Jiang, J. Xu, and X. Zhang, PLoS One, 2012. 7(5): p. e37381; PMID[22615996].

[PubMed]. HIV_0511-052412.

13. Synthesis and Biological Evaluation of Andrographolide Derivatives as Potent anti-HIV Agents. Tang, C., Y. Liu, B. Wang, G. Gu, L. Yang, Y. Zheng, H. Qian, and W. Huang, Archiv der Pharmazie (Weinheim), 2012. [Epub ahead of print]; PMID[22592973].

[PubMed]. HIV_0511-052412.

14. IFN-lambda Inhibits HIV-1 Integration and Post-transcriptional Events in Vitro, but There Is Only Limited in Vivo Repression of Viral Production. Tian, R.R., H.X. Guo, J.F. Wei, C.K. Yang, S.H. He, and J.H. Wang, Antiviral Research, 2012. [Epub ahead of print]; PMID[22584351].

[PubMed]. HIV_0511-052412.

15. Benzophenone Glycosides and Epicatechin Derivatives from Malania oleifera. Wu, X.D., J.T. Cheng, J. He, X.J. Zhang, L.B. Dong, X. Gong, L.D. Song, Y.T. Zheng, L.Y. Peng, and Q.S. Zhao, Fitoterapia, 2012. [Epub ahead of print]; PMID[22609684].

[PubMed]. HIV_0511-052412.

16. Characterization of a Peptide Domain within the GB Virus C Envelope Glycoprotein (E2) That Inhibits HIV Replication. Xiang, J., J.H. McLinden, T.M. Kaufman, E.L. Mohr, N. Bhattarai, Q. Chang, and J.T. Stapleton, Virology, 2012. [Epub ahead of print]; PMID[22608061].

[PubMed]. HIV_0511-052412.

17. Crystal Structures of Multidrug-resistant HIV-1 Protease in Complex with Two Potent Anti-malarial Compounds. Yedidi, R.S., Z. Liu, Y. Wang, J.S. Brunzelle, I.A. Kovari, P.M. Woster, L.C. Kovari, and D. Gupta, Biochemical and Biophysical Research Communications, 2012. 421(3): p. 413-417; PMID[22469467].

[PubMed]. HIV_0511-052412.

18. EGCG Inhibits Tat-induced LTR Transactivation: Role of Nrf2, AKT, AMPK Signaling Pathway. Zhang, H.S., T.C. Wu, W.W. Sang, and Z. Ruan, Life Sciences, 2012. 90(19-20): p. 747-754; PMID[22480519].

[PubMed]. HIV_0511-052412.

19. Preclinical Development of TLR Ligands as Drugs for the Treatment of Chronic Viral Infections. Zhang, X., A. Kraft, R. Broering, J.F. Schlaak, U. Dittmer, and M. Lu, Expert Opinion on Drug Discovery, 2012. [Epub ahead of print]; PMID[22607384].

[PubMed]. HIV_0511-052412.

ISI Web of Knowledge Citations

20. A Role of Template Cleavage in Reduced Excision of Chain-terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation. Acosta-Hoyos, A.J., S.E. Matsuura, P.R. Meyer, and W.A. Scott, Journal of Virology, 2012. 86(9): p. 5122-5133; ISI[000302777800035].

[WOS]. HIV_0511-052412.

21. Synthesis and anti-HIV Activities of Suramin Conjugates of 3 '-Fluoro-2 ',3 '-dideoxythymidine and 3 '-Azido-2 ',3 '-dideoxythymidine. Agarwal, H.K., G.F. Doncel, and K. Parang, Medicinal Chemistry, 2012. 8(2): p. 193-197; ISI[000302993200008].

[WOS]. HIV_0511-052412.

22. Electronic Structure and Spectroscopic Properties of anti-HIV Active Aminophenols. Bazyl, O.K., V.Y. Artyukhov, G.V. Maier, G.B. Tolstorozhev, T.F. Raichenok, I.V. Skornyakov, O.I. Shadyro, V.L. Sorokin, and G.A. Ksendzova, Optics and Spectroscopy, 2012. 112(2): p. 223-232; ISI[000303154300012].

[WOS]. HIV_0511-052412.

23. Single-domain Antibody-SH3 Fusions for Efficient Neutralization of HIV-1 Nef Functions. Bouchet, J., C. Herate, C.A. Guenzei, C. Verollet, A. Jarviluoma, J. Mazzolini, S. Rafie, P. Chames, D. Baty, K. Saksela, F. Niedergang, I. Maridonneau-Parini, and S. Benichou, Journal of Virology, 2012. 86(9): p. 4856-4867; ISI[000302777800013].

[WOS]. HIV_0511-052412.

24. Cyclic Peptide Inhibitors of HIV-1 Capsid-human Lysyl-tRNA Synthetase Interaction. Dewan, V., T. Liu, K.M. Chen, Z.Q. Qian, Y. Xiao, L. Kleiman, K.V. Mahasenan, C.L. Li, H. Matsuo, D.H. Pei, and K. Musier-Forsyth, ACS Chemical Biology, 2012. 7(4): p. 761-769; ISI[000302977300019].

[WOS]. HIV_0511-052412.

25. Identification of HIV-1 Reverse Transcriptase Dual Inhibitors by a Combined Shape-, 2D-fingerprint- and Pharmacophore-based Virtual Screening Approach. Distinto, S., F. Esposito, J. Kirchmair, M.C. Cardia, M. Gaspari, E. Maccioni, S. Alcaro, P. Markt, G. Wolber, L. Zinzula, and E. Tramontano, European Journal of Medicinal Chemistry, 2012. 50: p. 216-229; ISI[000303284400024].

[WOS]. HIV_0511-052412.

26. Design, Synthesis, and Biological Activity of Novel 1,4-Disubstituted piperidine/piperazine Derivatives as CCR5 Antagonist-based HIV-1 Entry Inhibitors. Dong, M.X., L. Lu, H.T. Li, X.H. Wang, H. Lu, S.B. Jiang, and Q.Y. Dai, Bioorganic & Medicinal Chemistry Letters, 2012. 22(9): p. 3284-3286; ISI[000302964300049].

[WOS]. HIV_0511-052412.

27. Lignan Derivatives from the Leaves Nicotiana tabacum and Their Activities. Gao, X.M., X.S. Li, X.Z. Yang, H.X. Mu, Y.K. Chen, G.Y. Yang, and Q.F. Hu, Heterocycles, 2012. 85(1): p. 147-153; ISI[000302848800012].

[WOS]. HIV_0511-052412.

28. Determination of anti-HIV Active Constituents of Helichrysum species by Means of Metabolomics. Heyman, H.M., V. Maharaj, C. Kenyon, and J.J.M. Meyer, South African Journal of Botany, 2012. 79: p. 189-189; ISI[000302978900071].

[WOS]. HIV_0511-052412.

29. Footprint-based Identification of Viral Entry Inhibitors Targeting HIVgp41. Holden, P.M., H. Kaur, R. Goyal, M. Gochin, and R.C. Rizzo, Bioorganic & Medicinal Chemistry Letters, 2012. 22(8): p. 3011-3016; ISI[000302768200078].

[WOS]. HIV_0511-052412.

30. The Combined anti-HIV-1 Activity of Emtricitabine and Tenofovir with the Integrase Inhibitors Elvitegravir or Raltegravir Show High Levels of Synergy in Vitro. Kulkarni, R., R. Hluhanich, D. McColl, M.E. Abram, M.D. Miller, and K. White, Hiv Medicine, 2012. 13: p. 29-29; ISI[000302951100084].

WOS]. HIV_0511-052412.

31. Sometimes It Takes Two to Tango: Contributions of Dimerization to Functions of Human Alpha-defensin HNP1 Peptide. Pazgier, M., G. Wei, B. Ericksen, G. Jung, Z.B. Wu, E. de Leeuw, W.R. Yuan, H. Szmacinski, W.Y. Lu, J. Lubkowski, and R.I. Lehrer, Journal of Biological Chemistry, 2012. 287(12): p. 8944-8953; ISI[000301797800025].

[WOS]. HIV_0511-052412.

32. Concise Synthesis of 2-Benzazepine Derivatives and Their Biological Activity. So, M., T. Kotake, K. Matsuura, M. Inui, and A. Kamimura, Journal of Organic Chemistry, 2012. 77(8): p. 4017-4028; ISI[000302982000031].

[WOS]. HIV_0511-052412.

33. Recent Advances in the Research of 2,3-Diaryl-1,3-thiazolidin-4-one Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Tian, Y., P. Zhan, D. Rai, J.Y. Zhang, E. De Clercq, and X.Y. Liu, Current Medicinal Chemistry, 2012. 19(13): p. 2026-2037; ISI[000303012900004].

[WOS]. HIV_0511-052412.

34. Exploring Marine Cyanobacteria for Lead Compounds of Pharmaceutical Importance. Uzair, B., S. Tabassum, M. Rasheed, and S.F. Rehman, Scientific World Journal, 2012: p. 1-10; ISI[000303246900001].

[WOS]. HIV_0511-052412.

35. Practical Synthesis of a Benzophenone-based NNRT Inhibitor of HIV-1. Wang, X.J., L. Zhang, X.F. Sun, H. Lee, D. Krishnamurthy, J.A. O'Meara, S. Landry, C. Yoakim, B. Simoneau, N.K. Yee, and C.H. Senanayake, Organic Process Research & Development, 2012. 16(4): p. 561-566; ISI[000302990200004].

[WOS]. HIV_0511-052412.

36. Hydroxyl May Not Be Indispensable for Raltegravir: Design, Synthesis and SAR Studies of Raltegravir Derivatives as HIV-1 Inhibitors. Wang, Z.W., M.X. Wang, X. Yao, Y. Li, W.T. Qiao, Y.Q. Geng, Y.X. Liu, and Q.M. Wang, European Journal of Medicinal Chemistry, 2012. 50: p. 361-369; ISI[000303284400039].

[WOS]. HIV_0511-052412.

37. Discovery of HIV Fusion Inhibitors Targeting gp41 Using a Comprehensive Alpha-helix Mimetic Library. Whitby, L.R., K.E. Boyle, L.F. Cai, X.Q. Yu, M. Gochin, and D.L. Boger, Bioorganic & Medicinal Chemistry Letters, 2012. 22(8): p. 2861-2865; ISI[000302768200045].

[WOS]. HIV_0511-052412.

38. Flavonoids and Antioxidative Enzymes in Temperature-challenged Roots of Scutellaria baicalensis Georgi. Yuan, Y., L.F. Shuai, S.Q. Chen, L.Q. Huang, S.S. Qin, and Z.C. Yang, Zeitschrift fur Naturforschung Section C-A Journal of Biosciences, 2012. 67(1-2): p. 77-85; ISI[000302843000010].

[WOS]. HIV_0511-052412.

Animal Studies

39. Macaque Studies of Vaccine and Microbicide Combinations for Preventing HIV-1 Sexual Transmission. Barouch, D.H., P.J. Klasse, J. Dufour, R.S. Veazey, and J.P. Moore, Proceedings of the National Academy of Sciences of the United States of America, 2012; PMID[22586094].

[PubMed]. HIV_0511-052412.

40. Pharmacokinetic Profiling of Efavirenz-Emtricitabine-Tenofovir Fixed Dose Combination in Pregnant and Non-pregnant Rats. Nirogi, R., G. Bhyrapuneni, V. Kandikere, N. Muddana, R. Saralaya, P. Komarneni, K. Mudigonda, and K. Mukkanti, Biopharmaceutics and Drug Disposition, 2012; PMID[22610784].

[PubMed]. HIV_0511-052412.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022